Smiths Medical, Inc. Offers Innovative Technology that Reduces the Need for Occlusion De-clotting Medication

Published: May 14, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today that there is an alternative product that decreases catheter occlusions, a common problem with IV catheters. Smiths Medical distributes Nexus TKO® (To Keep Open) needleless connectors, a solution that can help healthcare facilities affected by the current supply constraint of the occlusion de-clotting medication Cathflo® Activase® (alteplase)2.

Help employers find you! Check out all the jobs and post your resume.

Back to news